— Know what they know.
Not Investment Advice
Also trades as: 0I3I.L (LSE) · $vol 0M

COO NASDAQ

The Cooper Companies, Inc.
1W: +4.1% 1M: -6.1% 3M: -25.2% YTD: -22.5% 1Y: -22.9% 3Y: -35.1% 5Y: -35.3%
$62.55
-0.30 (-0.48%)
 
Weekly Expected Move ±3.3%
$56 $58 $60 $62 $64
NASDAQ · Healthcare · Medical - Instruments & Supplies · Alpha Radar Neutral · Power 47 · $12.2B mcap · 194M float · 1.13% daily turnover · Short 29% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$4.1B +5.1% ▲
5Y CAGR: +11.0%
Gross Profit
$2.5B -4.3% ▼
5Y CAGR: +10.1%
Operating Income
$683M -3.2% ▼
5Y CAGR: +17.0%
Net Income
$375M -4.4% ▼
5Y CAGR: +9.5%
EPS (Diluted)
$1.87 -4.6% ▼
5Y CAGR: -17.2%
EBITDA
$1.1B -1.7% ▼
5Y CAGR: +12.3%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$2.9B$3.3B$3.6B$3.9B$4.1B
YoY Growth+20.2%+13.2%+8.6%+8.4%+5.1%
Cost of Revenue$967M$1.2B$1.2B$1.3B$1.6B
Gross Profit$2.0B$2.1B$2.4B$2.6B$2.5B
Gross Margin66.9%64.7%65.6%66.6%60.7%
R&D Expenses$93M$110M$137M$155M$172M
SG&A Expenses$1.2B$1.3B$1.5B$1.5B$1.6B
Operating Expenses$1.4B$1.6B$1.8B$1.9B$1.8B
Operating Income$506M$508M$533M$706M$683M
Operating Margin17.3%15.3%14.8%18.1%16.7%
Interest Expense$23M$57M$105M$114M$100M
Income Before Tax$492M$475M$413M$582M$566M
Tax Expense-$2.5B$90M$119M$190M$192M
Net Income$2.9B$386M$294M$392M$375M
Net Margin100.8%11.7%8.2%10.1%9.2%
EPS (Diluted)$59.07$1.94$1.48$1.96$1.87
EBITDA$824M$879M$886M$1.1B$1.1B
Shares Outstanding50M199M199M200M200M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms